African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 6, June 2025 | pp. 166–176

DOI: 10.46882/AJIDR/148796

Article Type: Research Article

Title: Molecular characterization and clarithromycin resistance mutations in Helicobacter pylori among patients with dyspepsia

Names of Authors: Youssef El-Masry¹*, Kenji Takahashi², Sofia Alvarez³

Authors’ Affiliations: ¹Department of Gastroenterology, Cairo University, Cairo, Egypt. ²Department of Microbiology, Kyoto University, Kyoto, Japan. ³Department of Internal Medicine, University of Buenos Aires, Buenos Aires, Argentina.

Abstract: Rising clarithromycin resistance significantly undermines the efficacy of standard triple therapy for Helicobacter pylori eradication. We investigated the prevalence of cagA and vacA virulence genotypes and 23S rRNA clarithromycin resistance mutations among dyspeptic patients undergoing upper endoscopy. Gastric biopsy specimens from 280 patients were analyzed using rapid urease testing, histology, and multiplex polymerase chain reaction. Helicobacter pylori infection was confirmed in 64.3 percent of patients, with A2143G and A2142G clarithromycin resistance mutations detected in 28.9 percent of positive biopsies. Prior macrolide exposure independently predicted resistance. Bismuth-based quadruple therapy is recommended as first-line treatment in high-resistance settings.

Keywords: Helicobacter pylori, Clarithromycin resistance, Dyspepsia, Virulence genotypes, Eradication therapy

Citation: El-Masry Y, Takahashi K, Alvarez S (2025). Molecular characterization and clarithromycin resistance mutations in Helicobacter pylori among patients with dyspepsia. African Journal of Infectious Diseases Research, 12(6): 166–176. DOI: 10.46882/AJIDR/148796

Manuscript Timeline: Received: April 26, 2025; Revised: May 28, 2025; Accepted: June 11, 2025; Published: June 20, 2025